Pharma Consulting Plays A Key Role In Improving Pharmaceutical Sales

Our healthcare system is extremely complicated, with a lot of moving parts, but is nevertheless one of our most important economic drivers. Within this industry, a new product must face complex restrictions and the attention of a variety of different parties. Before a solution to the patient's problem may be presented, it has to face a complex path from the scientist at one end to the sufferer at the other. In the dissemination of information, pharmaceutical consultants help to ensure that all those who have an input into the decision-making process are fully aware of all the repercussions.

A pharmaceutical company is far more than just a manufacturer of health products and solutions. As a pharmaceutical consulting firm stresses, the company owes the consumer in general a debt of revelation. Pharmaceutical companies regularly operate on the sharp end of discovery and their revelations may be truly ground-breaking. Without an adequate marketing channel, these findings might never make their way via the regulators to the front-line professionals. Marketing also insists that the product features and benefits are correctly communicated to the financiers, principally the insurance companies, who seem to have an ever-increasing role in the dissemination of care.

Before a new product may arrive on the desk of the regulators, who determine its future, the company must have marketed both its products and its history within a very competitive and busy environment. It should be noted that certain principals within the industry have an incentive to steer healthcare practitioners and their patients toward older, or generic medications and that these agendas may not be in the best interests of the sufferer. Pharmaceutical companies must create a position within such a difficult marketplace, in order to push science and discovery and their own significant position forward.

Sometimes, the vested interests are very powerful and do not serve the ultimate client best. In popular opinion, healthcare reform is always controversial and the pharmaceutical company would do well to accurately and forcefully communicate its position. The physician takes input from many different sources before he or she makes the decision as to final care, including experience, peer input, education and training, patient history, formularies, techniques and benchmarks - all play their role. Statistics tell us that 90% of the most frequently prescribed drugs are generics and thus it is difficult for pharmaceutical companies to ensure that they are being heard in the right place at the right time. In most cases, pharma consulting firms are used to this difficult environment and can certainly help to open channels and engage practices.

Pharmaceutical companies have been responsible for many of the most amazing discoveries in the world of medicine. Cures that would have been unheard-of a generation ago are now commonplace. Much emphasis must be put on marketing “the word” to ensure that our health care continues to improve.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.